12:00 AM
Mar 17, 2008
 |  BioCentury  |  Regulation

ITP pipeline

ITP pipeline

Company Product Description Status
Amgen (NASDAQ:AMGN) Nplate romiplostim Platelet growth factor peptibody engineered with Fc receptor Registration...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >